European Journal of Pediatrics

, Volume 168, Issue 2, pp 181–185

Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease

  • Keiko Okada
  • Junichi Hara
  • Ichiro Maki
  • Kazunori Miki
  • Kouji Matsuzaki
  • Taro Matsuoka
  • Takehisa Yamamoto
  • Toshinori Nishigaki
  • Syunji Kurotobi
  • Tetsuya Sano
  • For the Osaka Kawasaki Disease Study Group
Original Paper

Abstract

Approximately 15–20% of patients with Kawasaki disease (KD) are not responsive to high-dose intravenous gammaglobulin (IVIG). We have previously reported a predictive method for identifying IVIG-non-responsive patients (high-risk KD patients). We determined the safety and effectiveness of pulse methylprednisolone with high-dose IVIG (mPSL+IVIG) as a primary treatment for high-risk KD patients. Sixty-two high-risk KD patients were treated with pulse methylprednisolone 30 mg/kg over 2 h, followed by IVIG 2 g/kg over 24 h (mPSL+IVIG group) and were compared with a historical control group of 32 high-risk patients treated with IVIG 2 g/kg alone at the participating hospitals before this study was opened (IVIG group). High-risk patients were identified with at least two of three predictors (C-reactive protein ≥7 mg/dL, total bilirubin ≥0.9 mg/dL or aspartate aminotransferase ≥200 IU/L). Sixty-six percent (95% confidence interval [CI] 54–78%) of patients had a prompt defervescence in the mPSL+IVIG group compared with 44% (95% CI 26–62%) for the IVIG group (p = 0.048). Coronary artery lesions were observed in 24.2% (95% CI 13.2–35.2%) and 46.9% (95% CI 28.6–65.2%) of patients in the mPSL+IVIG and IVIG groups, respectively (p = 0.025). This is the first report showing that mPSL+IVIG is effective and safe as a primary treatment for high-risk KD patients.

Keywords

Kawasaki disease Methylprednisolone Coronary disease 

Abbreviations

IVIG

Intravenous gammaglobulin

KD

Kawasaki disease

mPSL

Methylprednisolone

References

  1. 1.
    Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK (2004) Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol 43:120–124PubMedCrossRefGoogle Scholar
  2. 2.
    Dale RC, Saleem MA, Daw S, Dillon MJ (2000) Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr 137:723–726PubMedCrossRefGoogle Scholar
  3. 3.
    Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, Dillon MJ, Deanfield JE (1996) Endothelial dysfunction late after Kawasaki disease. Circulation 94:2103–2106PubMedGoogle Scholar
  4. 4.
    Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145–148PubMedCrossRefGoogle Scholar
  5. 5.
    Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, Kawarano M, Baba K, Mori C (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2:1055–1058PubMedCrossRefGoogle Scholar
  6. 6.
    Inoue Y, Okada Y, Shinohara M, Kobayashi T, Kobayashi T, Tomomasa T, Takeuchi K, Morikawa A (2006) A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr 149:336–341PubMedCrossRefGoogle Scholar
  7. 7.
    Jibiki T, Terai M, Kurosaki T, Nakajima H, Suzuki K, Inomata H, Terashima I, Honda T, Yasukawa K, Hamada H, Kohno Y (2004) Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease. Eur J Pediatr 163:229–233PubMedCrossRefGoogle Scholar
  8. 8.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733PubMedCrossRefGoogle Scholar
  9. 9.
    Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP; Pediatric Heart Network Investigators (2007) Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 15:663–675CrossRefGoogle Scholar
  10. 10.
    Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131–137PubMedCrossRefGoogle Scholar
  11. 11.
    Wallace CA, French JW, Kahn SJ, Sherry DD (2000) Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 105:E78PubMedCrossRefGoogle Scholar
  12. 12.
    Wright DA, Newburger JW, Baker A, Sundel RP (1996) Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 128:146–149PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Keiko Okada
    • 1
  • Junichi Hara
    • 1
  • Ichiro Maki
    • 2
  • Kazunori Miki
    • 3
  • Kouji Matsuzaki
    • 4
  • Taro Matsuoka
    • 5
  • Takehisa Yamamoto
    • 6
  • Toshinori Nishigaki
    • 7
  • Syunji Kurotobi
    • 8
  • Tetsuya Sano
    • 9
  • For the Osaka Kawasaki Disease Study Group
  1. 1.Department of Pediatric Hematology/OncologyOsaka City General HospitalMiyakojima-ku, OsakaJapan
  2. 2.Ikeda Municipal HospitalOsakaJapan
  3. 3.Itami Municipal HospitalHyogoJapan
  4. 4.Suita Municipal HospitalOsakaJapan
  5. 5.Toyonaka Municipal HospitalOsakaJapan
  6. 6.Mino City HospitalOsakaJapan
  7. 7.Osaka Keisatsu HospitalOsakaJapan
  8. 8.Osaka University Graduate School of MedicineOsakaJapan
  9. 9.Osaka Kosei-nenkin HospitalOsakaJapan

Personalised recommendations